Searched for
VIVEK R MISRA
Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...- RPG Group hires 7 CXOs amid pandemic lockdownMumbai-based RPG Group created some new roles to help build capability in new markets or functions. The group is also looking at hiring dig...
- Buy Jubilant Life Sciences, price target Rs 580: Kunal BothraThe analyst suggested a stoploss at Rs 537 .
- Buy ONGC, price target Rs 136: Chandan TapariaThe analyst suggested a stoploss at Rs 124.
- Buy Oil And Natural Gas Corporation, price target Rs 132: Jay ThakkarThe analyst suggested a stoploss at Rs 122 .
- Buy Jubilant Life Sciences, price target Rs 575: Kunal BothraThe analyst suggested a stoploss at Rs 533.
- Geojit Financial maintains hold on ONGC, target price Rs 137The brokerage cited lower than expected September quarter results for the rating.
- Buy ONGC, price target Rs 140: Shrikant ChouhanThe analyst suggested a stoploss at Rs 129.9.
- Sell ONGC, target price Rs 115: Sagar DoshiSagar Doshi recommended to keep a stop loss at Rs 133.
- Neutral Jubilant Life Sciences, target Rs 905: Motilal Oswal SecuritiesMotilal Oswal Securities is neutral Jubilant Life Sciences at a price target of Rs 905. The time period given to achieve the target is a qu...
- Start nibbling at sharply-down stocks, but don't go whole hog: Vivek R Misra, Societe Generale'We do believe that the Indian economy will start picking up and we should start seeing better numbers in the quarters ahead.'
- FPIs stay bullish on India despite China, US worriesIndian equities had lost some lure in the first half of 2015 when Chinese stocks surged and global investors feared that reforms in India c...
- India regains most ‘favoured’ market status among global investorsInvestors expect the Indian equities to receive a bigger share of the incremental flows coming into Emerging markets.
- Volatility to intensify as crucial US Fed Sept policy meet draws near: Vivek R Misra, Societe Generale"We think that the Fed is likely to start hiking rates beginning September since the decision is likely to be very data-dependent."
- Not much downside left; bet on private banks, IT, auto sectors: Vivek R Misra, Societe GeneraleI would favour the cyclical sectors right now. My top pick would be banks, followed by stocks in industrial, auto and the IT sector.
- Snapdeal names Silicon Valley veteran Gaurav Gupta as Vice-President, EngineeringGupta will spearhead Snapdeal’s cloud platform and technology infrastructure, according to a press statement released by the company.
- See Sensex at 32,500 by end of 2015, and at 38,000 by end of 2016: Vivek R Misra, Societe Generale"I think that volatility will last a bit longer — probably for about one to two quarters more. After that we should see Indian markets movi...
- Expect markets to move up from here; see Sensex @32,500 by end of 2015: Vivek R Misra, Societe Generale"Talking of sectors, we favour cyclicals. Banks are our top pick. Besides that, we like industrials, IT and the discretionary consumer spac...
- Top three key risks for markets from RBI policyWe have highlighted key risks from the RBI policy, which could act as a deterrent to markets.
- Pre-hire negotiations: Severance packages new buzzword among would-be India Inc CEOsNow, it is not just CEOs, severance packages are also being designed for the top four to five positions in a company.
Load More
